(Press-News.org) (Toronto, November 18, 2024) A recent study published in the Journal of Medical Internet Research introduced the EDAI framework, a comprehensive guideline designed to embed equity, diversity, and inclusion (EDI) principles throughout the artificial intelligence (AI) lifecycle. Led by Dr Samira Abbasgholizadeh-Rahimi, PhD, the Canada Research Chair (Tier II) in AI and Advanced Digital Primary Health Care, the research addresses a significant gap in current AI development and implementation practices in health and oral health care, which often overlook critical EDI factors. With EDAI, AI developers, policymakers, and health care providers now have a roadmap to ensure AI systems are not only technologically sound but also socially responsible and accessible to all.
Through a 3-phase research approach, including a systematic literature review and two international workshops with over 60 experts and community representatives, the research team identified essential EDI indicators to weave into each stage of AI lifecycle, from data collection to deployment. Co-designed with input from diverse voices, this framework puts inclusion at the forefront, ensuring that AI in health and oral health care reflects a range of perspectives and serves everyone more equitably and responsibly.
“The AI systems of today are often mirrors reflecting our societal biases rather than windows to a more equitable future. To use AI's power for societal good, we must ensure using frameworks like EDAI to integrate EDI into its lifecycle. Only then can we transform these powerful tools into bridges that connect and uplift everyone, not just the privileged few.” said Dr Rahimi.
The study funded by the Canadian Institutes of Health Research (CIHR) and the Research Funds of Quebec (FRQ) network i.e., Oral and Oral Health Research Network (RSBO), shows that embedding EDI principles into AI is about much more than just checking a box—it’s about tackling deeper biases within systems and organizations that can prevent AI from truly working for everyone. For example, the EDAI framework can be used by AI developers to design diagnostic tools that consider demographic and cultural diversity. Developers can ensure that datasets include diverse populations, enabling AI to provide accurate diagnoses across various demographics, and preventing biases that traditionally affected certain groups.
Similarly, when designing AI for health care management (like scheduling or resource allocation), using EDAI framework during design could ensure equitable health care by optimizing these systems to prioritize underrepresented or underserved communities. For instance, using EDAI, an AI-based patient scheduling system could be carefully developed and implemented with EDI principles in mind to identify underserved communities and marginalized groups facing accessibility challenges and facilitate access to care for these populations.
Along with offering practical steps and guidance, the EDAI framework sheds light on both the roadblocks and facilitators that can affect how EDI principles are incorporated, giving developers and policymakers the insight to tackle challenges and boost the framework’s impact. This initiative is setting the stage for a new standard in AI development and implementation, redefining how AI can enhance health and oral health care for everyone, regardless of background or circumstances.
###
About JMIR Publications:
JMIR Publications, celebrating its 25th anniversary in 2024, is a leading open access digital health research publisher. As a pioneer in open access publishing, JMIR Publications is committed to driving innovation in scholarly communications, advancing digital health research, and promoting open science principles. Our portfolio features 35 open access, peer-reviewed journals dedicated to the dissemination of high-quality research in the field of digital health, including the Journal of Medical Internet Research, as well as cross-disciplinary journals such as JMIR Research Protocols and the new title JMIR XR & Spatial Computing.
To learn more about JMIR Publications, please visit jmirpublications.com or connect with us via Twitter, LinkedIn, YouTube, Facebook, and Instagram.
Head office: 130 Queens Quay East, Unit 1100, Toronto, ON, M5A 0P6 Canada
Media contact: communications@jmir.org
The content of this communication is licensed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, published by JMIR Publications, is properly cited.
END
Black holes are one of the most enigmatic stellar objects. While best known for swallowing up their surroundings into a gravity pit from which nothing can escape, they can also shoot off powerful jets of charged particles, leading to explosive bursts of gamma rays that can release more energy in mere seconds than our sun will emit in its entire lifetime. For such a spectacular event to occur, a black hole needs to carry a powerful magnetic field. Where this magnetism comes from, however, has been a long-standing ...
Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in mental health conditions like schizophrenia or depression.
Remembering a code for long enough to type it in; holding a conversation and reacting appropriately to what is being said: in everyday situations like these, we use our working memory. It allows a memory to be actively retained for a few seconds. Certain conditions, such as schizophrenia ...
Cambridge, MA (November 18, 2024) – Today the MIT Press is releasing a workshop report on what additional information is needed to ensure that open access publication benefits research, entitled "Access to Science & Scholarship 2024: Building an Evidence Base to Support the Future of Open Research Policy." The report is the outcome of a workshop funded by the National Science Foundation and held at the D.C. headquarters of the American Association for the Advancement of Science on September 20, 2024.
The implementation of open access has resulted in consolidation of the publishing industry, an explosion in unreviewed articles, and new costs that may be hard ...
Quebec, CA, November 18, 2024 – A new study published in the The Journal of Nutrition, found that substituting two tablespoons of pure maple syrup for refined sugars reduced several cardiometabolic risk factors in humans. It was the first placebo-controlled clinical trial exploring potential health benefits of maple syrup in humans.
“We know from decades of research that maple syrup is more than just sugar. It contains over 100 natural compounds, including polyphenols, that are known to prevent disease in part through their anti-inflammatory ...
MINNEAPOLIS / ST. PAUL (11/18/2024) — A new study by researchers at the University of Minnesota Twin Cities in collaboration with the Minnesota Department of Natural Resources (DNR) found that specific insecticides, called neonicotinoids, were found at high concentrations in some ground and surface water sources that could affect drinking water.
Individuals relying on shallow groundwater or natural springs for drinking water have a higher risk of contamination from these insecticides compared to those getting their drinking water from deep groundwater wells. ...
The €500,000 Einstein Foundation Award for Promoting Quality in Research honors researchers and institutions whose work helps to fundamentally advance the quality and robustness of research findings. The award is bestowed jointly with the QUEST Center for Responsible Research, Berlin Institute of Health (BIH) at Charité. „The Einstein Foundation Award seeks to amplify the importance of quality and accountability in research, particularly as science plays a critical role in addressing global challenges,“ explains Martin Rennert, Chair of the Einstein Foundation’s Executive Board. ...
Mitochondrial diseases are among the most prevalent hereditary metabolic disorders, known to occur in one out every 5000 births. Single nucleotide variations, indels, and structural variations are known to cause these disorders. While many arise from single nucleotide variations, indels, or structural variants, some forms are also triggered by repeat expansions in nuclear genes affecting mitochondrial function, which can result in severe mitochondrial dysfunction. These diseases often impact the central nervous system (CNS), and mitochondrial encephalopathies represent a subset characterized by prominent ...
Minuscule particles of plastic are not only bad for the environment. A study led from Umeå University, Sweden, has shown that the so-called nanoplastics which enter the body also can impair the effect of antibiotic treatment. The results also indicate that the nanoplastics may lead to the development of antibiotic resistance. Even the indoor air in our homes contains high levels of nanoplastics from, among other things, nylon, which is particularly problematic.
"The results are alarming considering how common nanoplastics are and because effective antibiotics for many can be the difference between life and death," says Lukas Kenner, ...
How can scientists across climate science, medical and psychological topics foster the public’s trust in them and their science? Show that they are intellectually humble.
Those are some of the findings of two intellectually humble University of Pittsburgh scientists and their co-authors, using five separate studies totaling 2,034 participants in research published Nov. 18 in Nature Human Behaviour.
“Research has shown that having intellectual humility — which is an awareness that one’s knowledge or beliefs might be incomplete or wrong — is associated with engaging in more effortful and less biased information processing,” said Jonah Koetke, ...
A promising daily tablet is effective at increasing height and improving proportional limb growth in children with achondroplasia, the most common form of dwarfism, according to a new study. And the findings could spare these children from needing to have a daily injection to boost growth.
The phase II study, led by Murdoch Children’s Research Institute (MCRI) and published in the New England Journal of Medicine, found the drug infigratinib, an investigational product, was safe and effective in treating children with achondroplasia aged 3-11 ...
